---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-21-001432"
form_type: "8-K/A"
ticker: "FUST"
cik: "0001636051"
company_name: "FUSE GROUP HOLDING INC."
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-28T23:58:43.165279+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fuse Group issues 100M shares for E-Mo Biotech; Xie becomes 31.97% owner

## Summary
- Fuse Group acquired all of E-Mo Biotech in exchange for 100 million common shares.
- E-Mo Biotech is a development-stage vaccine/immunology/diagnostics firm with no commercial sales.
- Qiyi Xie receives 57.25M shares (31.97% of Fuse Group) and becomes largest shareholder, replacing Landbond Home.
- Shares issued to Xie under Reg D; to other sellers under Reg S; no underwriter used.

## SEC filing metadata
- accession: 0001185185-21-001432
- form_type: 8-K/A
- ticker: FUST
- cik: 0001636051
- company_name: FUSE GROUP HOLDING INC.
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 5.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636051/000118518521001432/0001185185-21-001432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636051/000118518521001432/fuseent20210929_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-21-001432
- JSON: https://secwatch.observer/filing/0001185185-21-001432.json
- Plain text: https://secwatch.observer/filing/0001185185-21-001432.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.